Skip to main content
Top
Published in: Abdominal Radiology 5/2016

01-05-2016 | Classics in Abdominal Imaging

The “Sausage” pancreas

Authors: Qiong Han, Halemane Ganesh, David J. DiSantis

Published in: Abdominal Radiology | Issue 5/2016

Login to get access

Excerpt

IgG4-related disease (IgG4RD) is a complex, immune-mediated illness characterized by lymphoplasmacytic infiltration of multiple organs, accompanied by an elevated serum IgG level [1]. Pancreatic involvement has been termed autoimmune pancreatitis (AIP) [2]. …
Literature
1.
go back to reference Zhang L, Smyrk T (2010) Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol 3(5):491–504PubMedPubMedCentral Zhang L, Smyrk T (2010) Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol 3(5):491–504PubMedPubMedCentral
2.
go back to reference Yoshida K, et al. (1995) Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568CrossRefPubMed Yoshida K, et al. (1995) Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568CrossRefPubMed
3.
go back to reference Bodily K, et al. (2009) Autoimmune pancreatitis: pancreatic and extrapancreatic imaging findings. AJR. 192(2):431–437CrossRefPubMed Bodily K, et al. (2009) Autoimmune pancreatitis: pancreatic and extrapancreatic imaging findings. AJR. 192(2):431–437CrossRefPubMed
Metadata
Title
The “Sausage” pancreas
Authors
Qiong Han
Halemane Ganesh
David J. DiSantis
Publication date
01-05-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 5/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0642-x

Other articles of this Issue 5/2016

Abdominal Radiology 5/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine